March 18, 2020 "Information
Clearing House" -
The
current coronavirus disease, Covid-19, has been
called a once-in-a-century
pandemic. But it may also be a once-in-a-century
evidence fiasco.
At a time when everyone needs better information,
from disease modelers and governments to people
quarantined or just social distancing, we lack
reliable evidence on how many people have been
infected with SARS-CoV-2 or who continue to become
infected. Better information is needed to guide
decisions and actions of monumental significance and
to monitor their impact.
Draconian countermeasures have been adopted in
many countries. If the pandemic dissipates — either
on its own or because of these measures — short-term
extreme social distancing and lockdowns may be
bearable. How long, though, should measures like
these be continued if the pandemic churns across the
globe unabated? How can policymakers tell if they
are doing more good than harm?
Vaccines or affordable treatments take many
months (or even years) to develop and test properly.
Given such timelines, the consequences of long-term
lockdowns are entirely unknown.
The data collected so far on how many people are
infected and how the epidemic is evolving are
utterly unreliable. Given the limited testing to
date, some deaths and probably the vast majority of
infections due to SARS-CoV-2 are being missed. We
don’t know if we are failing to capture infections
by a factor of three or 300. Three months after the
outbreak emerged, most countries, including the
U.S., lack the ability to test a large number of
people and no countries have reliable data on the
prevalence of the virus in a representative random
sample of the general population.
Are You Tired Of
The Lies And
Non-Stop Propaganda?
|
This evidence fiasco creates tremendous
uncertainty about the risk of dying from
Covid-19. Reported case fatality rates, like
the official 3.4% rate from the World Health
Organization, cause horror — and are
meaningless. Patients who have been tested
for SARS-CoV-2 are disproportionately those
with severe symptoms and bad outcomes. As
most health systems have limited testing
capacity, selection bias may even worsen in
the near future.
The one situation where an entire, closed
population was tested was the Diamond Princess
cruise ship and its quarantine passengers. The case
fatality rate there was 1.0%, but this was a largely
elderly population, in which the death rate from
Covid-19 is much higher.
Projecting the Diamond Princess mortality rate
onto the age structure of the U.S. population, the
death rate among people infected with Covid-19 would
be 0.125%. But since this estimate is based on
extremely thin data — there were just seven deaths
among the 700 infected passengers and crew — the
real death rate could stretch from five times lower
(0.025%) to five times higher (0.625%). It is also
possible that some of the passengers who were
infected might die later, and that tourists may have
different frequencies of chronic diseases — a risk
factor for worse outcomes with SARS-CoV-2 infection
— than the general population. Adding these extra
sources of uncertainty, reasonable estimates for the
case fatality ratio in the general U.S. population
vary from 0.05% to 1%.
That huge range markedly
affects how severe the pandemic is and what should
be done. A population-wide case fatality rate of
0.05% is lower than seasonal influenza. If that is
the true rate, locking down the world with
potentially tremendous social and financial
consequences may be totally irrational. It’s like an
elephant being attacked by a house cat. Frustrated
and trying to avoid the cat, the elephant
accidentally jumps off a cliff and dies.
Could the Covid-19 case fatality rate be that
low? No, some say, pointing to the high rate in
elderly people. However, even some so-called mild or
common-cold-type coronaviruses that have been known
for decades can have case fatality rates
as high as 8% when they infect elderly people in
nursing homes. In fact, such “mild” coronaviruses
infect tens of millions of people every year, and
account for
3% to 11% of those hospitalized in the U.S. with
lower respiratory infections each winter.
These “mild” coronaviruses may be implicated in
several thousands of deaths every year worldwide,
though the vast majority of them are not documented
with precise testing. Instead, they are lost as
noise among 60 million deaths from various causes
every year.
Although successful surveillance systems have
long existed for influenza, the disease is confirmed
by a laboratory in a tiny minority of cases. In the
U.S., for example, so far this season
1,073,976 specimens have been tested and 222,552
(20.7%) have tested positive for influenza. In the
same period, the estimated number of influenza-like
illnesses is between 36,000,000 and 51,000,000, with
an estimated 22,000 to 55,000 flu deaths.
Note the uncertainty about influenza-like illness
deaths: a 2.5-fold range, corresponding to tens of
thousands of deaths. Every year, some of these
deaths are due to influenza and some to other
viruses, like common-cold coronaviruses.
In
an autopsy series that tested for respiratory
viruses in specimens from 57 elderly persons who
died during the 2016 to 2017 influenza season,
influenza viruses were detected in 18% of the
specimens, while any kind of respiratory virus was
found in 47%. In some people who die from viral
respiratory pathogens, more than one virus is found
upon autopsy and bacteria are often superimposed. A
positive test for coronavirus does not mean
necessarily that this virus is always primarily
responsible for a patient’s demise.
If we assume that case fatality rate among
individuals infected by SARS-CoV-2 is 0.3% in the
general population — a mid-range guess from my
Diamond Princess analysis — and that 1% of the U.S.
population gets infected (about 3.3 million people),
this would translate to about 10,000 deaths. This
sounds like a huge number, but it is buried within
the noise of the estimate of deaths from
“influenza-like illness.” If we had not known about
a new virus out there, and had not checked
individuals with PCR tests, the number of total
deaths due to “influenza-like illness” would not
seem unusual this year. At most, we might have
casually noted that flu this season seems to be a
bit worse than average. The media coverage would
have been less than for an NBA game between the two
most indifferent teams.
Some worry that the 68 deaths from Covid-19 in
the U.S.
as of March 16 will increase exponentially to
680, 6,800, 68,000, 680,000 … along with similar
catastrophic patterns around the globe. Is that a
realistic scenario, or bad science fiction? How can
we tell at what point such a curve might stop?
The most valuable piece of information for
answering those questions would be to know the
current prevalence of the infection in a random
sample of a population and to repeat this exercise
at regular time intervals to estimate the incidence
of new infections. Sadly, that’s information we
don’t have.
In the absence of data, prepare-for-the-worst
reasoning leads to extreme measures of social
distancing and lockdowns. Unfortunately,
we do not know if these measures work. School
closures, for example, may reduce transmission
rates. But they may also backfire if children
socialize anyhow, if school closure leads children
to spend more time with susceptible elderly family
members, if children at home disrupt their parents
ability to work, and more. School closures may also
diminish the chances of developing herd immunity in
an age group that is spared serious disease.
This has been the perspective behind the
different stance of the United Kingdom
keeping schools open, at least until as I write
this. In the absence of data on the real course of
the epidemic, we don’t know whether this perspective
was brilliant or catastrophic.
Flattening the curve to avoid overwhelming the
health system is conceptually sound — in theory. A
visual that has become viral in media and social
media shows how flattening the curve reduces the
volume of the epidemic that is above the threshold
of what the health system can handle at any moment.
Yet if the health system does become overwhelmed,
the majority of the extra deaths may not be due to
coronavirus but to other common diseases and
conditions such as heart attacks, strokes, trauma,
bleeding, and the like that are not adequately
treated. If the level of the epidemic does overwhelm
the health system and extreme measures have only
modest effectiveness, then flattening the curve may
make things worse: Instead of being overwhelmed
during a short, acute phase, the health system will
remain overwhelmed for a more protracted period.
That’s another reason we need data about the exact
level of the epidemic activity.
One of the bottom lines is that we don’t know how
long social distancing measures and lockdowns can be
maintained without major consequences to the
economy, society, and mental health. Unpredictable
evolutions may ensue, including financial crisis,
unrest, civil strife, war, and a meltdown of the
social fabric. At a minimum, we need unbiased
prevalence and incidence data for the evolving
infectious load to guide decision-making.
In the most pessimistic scenario, which I do not
espouse, if the new coronavirus infects 60% of the
global population and 1% of the infected people die,
that will translate into more than 40 million deaths
globally, matching the 1918 influenza pandemic.
The vast majority of this hecatomb would be
people with limited life expectancies. That’s in
contrast to 1918, when many young people died.
One can only hope that, much like in 1918, life
will continue. Conversely, with lockdowns of months,
if not years, life largely stops, short-term and
long-term consequences are entirely unknown, and
billions, not just millions, of lives may be
eventually at stake.
If we decide to jump off the cliff, we need some
data to inform us about the rationale of such an
action and the chances of landing somewhere safe.
John P.A. Ioannidis is professor of medicine,
of epidemiology and population health, of biomedical
data science, and of statistics at Stanford
University and co-director of Stanford’s
Meta-Research Innovation Center. -
"Source"
Do you agree or disagree? Post
your comment here
|